Literature DB >> 21221384

Approches actuelles au traitement du zona: Aspects controversés du traitement du zona.

R Bissonnette, G Leclerc.   

Abstract

Herpes zoster is a very common pathology. A description of its clinical presentation and treatment in both immunocompromised and immunocompetent patients is provided. There is also a discussion of controversial aspects of treatment in the light of recent medical findings.

Entities:  

Year:  1992        PMID： 21221384      PMCID： PMC2146080     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


  23 in total

1.  THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS.

Authors:  R E HOPE-SIMPSON
Journal:  Proc R Soc Med       Date:  1965-01

2.  Oral acyclovir in acute herpes zoster.

Authors:  M W McKendrick; J I McGill; J E White; M J Wood
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-13

3.  The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster.

Authors:  W H Eaglstein; R Katz; J A Brown
Journal:  JAMA       Date:  1970-03-09       Impact factor: 56.272

4.  Topical acyclovir treatment of herpes zoster in immunocompromised patients.

Authors:  M J Levin; J A Zaia; B J Hershey; L G Davis; G V Robinson; A C Segreti
Journal:  J Am Acad Dermatol       Date:  1985-10       Impact factor: 11.527

5.  ACTH versus prednisone and placebo in herpes zoster treatment.

Authors:  O J Clemmensen; K E Andersen
Journal:  Clin Exp Dermatol       Date:  1984-11       Impact factor: 3.470

6.  Population-based study of herpes zoster and its sequelae.

Authors:  M W Ragozzino; L J Melton; L T Kurland; C P Chu; H O Perry
Journal:  Medicine (Baltimore)       Date:  1982-09       Impact factor: 1.889

7.  Do corticosteroids prevent post-herpetic neuralgia?

Authors:  K Keczkes; A M Basheer
Journal:  Br J Dermatol       Date:  1980-05       Impact factor: 9.302

8.  Amitriptyline versus placebo in postherpetic neuralgia.

Authors:  C P Watson; R J Evans; K Reed; H Merskey; L Goldsmith; J Warsh
Journal:  Neurology       Date:  1982-06       Impact factor: 9.910

9.  Oral acyclovir in the treatment of acute herpes zoster ophthalmicus.

Authors:  L M Cobo; G N Foulks; T Liesegang; J Lass; J E Sutphin; K Wilhelmus; D B Jones; S Chapman; A C Segreti; D H King
Journal:  Ophthalmology       Date:  1986-06       Impact factor: 12.079

10.  Acyclovir halts progression of herpes zoster in immunocompromised patients.

Authors:  H H Balfour; B Bean; O L Laskin; R F Ambinder; J D Meyers; J C Wade; J A Zaia; D Aeppli; L E Kirk; A C Segreti; R E Keeney
Journal:  N Engl J Med       Date:  1983-06-16       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.